Showing results (101-110 of 214) with videos related to
Sort By:
Pageof 22
Hepatology (Baltimore, Md.)|October 30, 2020
Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart StudyMichelle T Long, Xiaoyu Zhang, Hanfei Xu, et al.BMC Cancer|July 13, 2016
Population attributable fraction of Esophageal squamous cell carcinoma due to smoking and alcohol in UgandaSamson Okello, Cristina Churchill, Rogers Owori, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 26, 2006
Outcomes and treatment of acute hepatitis C virus infection in a United States populationKathleen E Corey, Andrew S Ross, Alysse Wurcel, et al.Journal of the American Chemical Society|April 7, 2012
Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virusMary A Rodgers, Valerie A Villareal, Esperance A Schaefer, et al.The Prostate|February 15, 1997
Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancerA Y Liu, E Corey, R L Vessella, et al.Alimentary Pharmacology & Therapeutics|March 12, 2019
Relationship between resolution of non-alcoholic steatohepatitis and changes in lipoprotein sub-fractions: a post-hoc analysis of the PIVENS trialKathleen E Corey, Laura A Wilson, Akif Altinbas, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 3, 2020
Brief Report: Relationship Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in Persons With HIVAlyson Kaplan, Tracey G Simon, Jacqueline B Henson, et al.Journal of Viral Hepatitis|June 23, 2011
Acute hepatitis C infection lowers serum lipid levelsK E Corey, J Mendez-Navarro, L L Barlow, et al.Journal of Clinical Pharmacology|June 14, 2005
Influence of coadministration on the pharmacokinetics of azimilide dihydrochloride and digoxinRoger D Toothaker, Alfred E Corey, Suzanne N Valentine, et al.Lipids in Health and Disease|October 17, 2024
MASLD in persons with HIV is associated with high cardiometabolic risk as evidenced by altered advanced lipoprotein profiles and targeted metabolomicsKung-Hung Lin, Eduardo Vilar-Gomez, Kathleen E Corey, et al.Pageof 22